Lista de obras - Mitchell S. Stark - Dominio Público Uruguay

A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL).

artículo científico publicado en 2008

A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma

artículo científico publicado en 2011

A single SNP in an evolutionary conserved region within intron 86 of the HERC2 gene determines human blue-brown eye color

artículo científico publicado en 2008

Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS.

artículo científico publicado en 2005

Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers

artículo científico publicado en 2010

Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study

artículo científico publicado en 2010

BRAF polymorphisms and risk of melanocytic neoplasia

artículo científico publicado en 2005

Characterization of the Melanoma miRNAome by Deep Sequencing

artículo científico publicado en 2010

Common sequence variants on 20q11.22 confer melanoma susceptibility

artículo científico publicado en 2008

Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues

scientific journal article

Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma.

artículo científico publicado en 2011

Defective decatenation checkpoint function is a common feature of melanoma.

artículo científico publicado en 2013

Defining the Molecular Genetics of Dermoscopic Naevus Patterns

article

Distinct histone modifications denote early stress-induced drug tolerance in cancer

artículo científico publicado en 2017

Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents

artículo científico publicado en 2006

Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing

artículo científico publicado en 2011

Gene Expression Array Analysis to Identify Candidate Tumor Suppressor Genes in Melanoma.

artículo científico publicado en 2017

Gene expression profiling in melanoma identifies novel downstream effectors of p14ARF.

artículo científico publicado en 2007

Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3

scientific journal article

Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays.

artículo científico publicado en 2007

Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: Increased carriage of TYR and OCA2 variants

scientific article published on 23 September 2020

High frequency of BRAF mutations in nevi

artículo científico publicado en 2002

High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk

scientific article published on 17 July 2019

High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMEL

article

Identification of ARHGEF17, DENND2D, FGFR3, and RB1 mutations in melanoma by inhibition of nonsense-mediated mRNA decay.

artículo científico publicado en 2008

Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor gene

artículo científico publicado en 2012

Lack of genetic and epigenetic changes in CDKN2A in melanocytic nevi.

artículo científico publicado en 2001

Large-Giant Congenital Melanocytic Nevi: Moving Beyond NRAS Mutations

artículo científico publicado en 2019

Localization of a novel melanoma susceptibility locus to 1p22

artículo científico publicado en 2003

MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations

artículo científico publicado en 2001

Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor

artículo científico publicado en 2011

Melanoma treatment guided by a panel of microRNA biomarkers

artículo científico publicado en 2017

Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanoma.

artículo científico

MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis.

artículo científico publicado en 2015

MicroRNA regulation of melanoma progression ⬇️

artículo científico publicado el 1 de abril de 2012

Microarray expression profiling in melanoma reveals a BRAF mutation signature.

artículo científico publicado en 2004

Molecular characterization of a t(9;12)(p21;q13) balanced chromosome translocation in combination with integrative genomics analysis identifies C9orf14 as a candidate tumor-suppressor

artículo científico publicado en 2007

Multiple interaction nodes define the postreplication repair response to UV-induced DNA damage that is defective in melanomas and correlated with UV signature mutation load

artículo científico publicado en 2019

Mutation analysis of the CDKN2A promoter in Australian melanoma families

article

Mutation analysis of theCDKN2A promoter in Australian melanoma families

article

Mutation of the tumour suppressor p33ING1b is rare in melanoma.

artículo científico publicado en 2006

Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma

artículo científico publicado en 2014

Osteopontin is a downstream effector of the PI3-kinase pathway in melanomas that is inversely correlated with functional PTEN.

artículo científico publicado en 2006

PI3-kinase subunits are infrequent somatic targets in melanoma.

artículo científico publicado en 2006

POT1 loss-of-function variants predispose to familial melanoma

artículo científico publicado en 2014

Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma

artículo científico publicado en 2008

Rapid screening of 4000 individuals for germ-line variations in the BRAF gene

artículo científico publicado en 2006

SiDCoN: a tool to aid scoring of DNA copy number changes in SNP chip data

artículo científico publicado en 2007

Single nucleotide polymorphisms in obesity-related genes and the risk of esophageal cancers

artículo científico publicado en 2008

Smchd1 regulates a subset of autosomal genes subject to monoallelic expression in addition to being critical for X inactivation

artículo científico publicado en 2013

Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis

artículo científico publicado en 2018

The "melanoma-enriched" microRNA miR-4731-5p acts as a tumour suppressor

artículo científico publicado en 2016

The BRAF and NRAS mutation prevalence in dermoscopic subtypes of acquired naevi reveals constitutive MAPK pathway activation.

artículo científico publicado en 2017

The M53I mutation in CDKN2A is a founder mutation that predominates in melanoma patients with Scottish ancestry

artículo científico publicado en 2007

The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis

artículo científico publicado en 2015

Transcriptional pathway signatures predict MEK addiction and response to selumetinib (AZD6244)

artículo científico

Whole-Exome Sequencing of Acquired Nevi Identifies Mechanisms for Development and Maintenance of Benign Neoplasms

artículo científico publicado en 2018

miR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma.

artículo científico publicado en 2015

miRNAs: back seat drivers no more

artículo científico publicado en 2014

webFOG: A web tool to map genomic features onto genes.

artículo científico publicado en 2010

Lista de obras de Mitchell S. Stark

A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL).

A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma

A single SNP in an evolutionary conserved region within intron 86 of the HERC2 gene determines human blue-brown eye color

Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS.

Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers

Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study

BRAF polymorphisms and risk of melanocytic neoplasia

Characterization of the Melanoma miRNAome by Deep Sequencing

Common sequence variants on 20q11.22 confer melanoma susceptibility

Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues

Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma.

Defective decatenation checkpoint function is a common feature of melanoma.

Defining the Molecular Genetics of Dermoscopic Naevus Patterns

Distinct histone modifications denote early stress-induced drug tolerance in cancer

Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents

Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing

Gene Expression Array Analysis to Identify Candidate Tumor Suppressor Genes in Melanoma.

Gene expression profiling in melanoma identifies novel downstream effectors of p14ARF.

Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3

Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays.

Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: Increased carriage of TYR and OCA2 variants

High frequency of BRAF mutations in nevi

High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk

High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMEL

Identification of ARHGEF17, DENND2D, FGFR3, and RB1 mutations in melanoma by inhibition of nonsense-mediated mRNA decay.

Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor gene

Lack of genetic and epigenetic changes in CDKN2A in melanocytic nevi.

Large-Giant Congenital Melanocytic Nevi: Moving Beyond NRAS Mutations

Localization of a novel melanoma susceptibility locus to 1p22

MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations

Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor

Melanoma treatment guided by a panel of microRNA biomarkers

Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanoma.

MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis.

MicroRNA regulation of melanoma progression ⬇️

Microarray expression profiling in melanoma reveals a BRAF mutation signature.

Molecular characterization of a t(9;12)(p21;q13) balanced chromosome translocation in combination with integrative genomics analysis identifies C9orf14 as a candidate tumor-suppressor

Multiple interaction nodes define the postreplication repair response to UV-induced DNA damage that is defective in melanomas and correlated with UV signature mutation load

Mutation analysis of the CDKN2A promoter in Australian melanoma families

Mutation analysis of theCDKN2A promoter in Australian melanoma families

Mutation of the tumour suppressor p33ING1b is rare in melanoma.

Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma

Osteopontin is a downstream effector of the PI3-kinase pathway in melanomas that is inversely correlated with functional PTEN.

PI3-kinase subunits are infrequent somatic targets in melanoma.

POT1 loss-of-function variants predispose to familial melanoma

Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma

Rapid screening of 4000 individuals for germ-line variations in the BRAF gene

SiDCoN: a tool to aid scoring of DNA copy number changes in SNP chip data

Single nucleotide polymorphisms in obesity-related genes and the risk of esophageal cancers

Smchd1 regulates a subset of autosomal genes subject to monoallelic expression in addition to being critical for X inactivation

Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis

The "melanoma-enriched" microRNA miR-4731-5p acts as a tumour suppressor

The BRAF and NRAS mutation prevalence in dermoscopic subtypes of acquired naevi reveals constitutive MAPK pathway activation.

The M53I mutation in CDKN2A is a founder mutation that predominates in melanoma patients with Scottish ancestry

The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis

Transcriptional pathway signatures predict MEK addiction and response to selumetinib (AZD6244)

Whole-Exome Sequencing of Acquired Nevi Identifies Mechanisms for Development and Maintenance of Benign Neoplasms

miR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma.

miRNAs: back seat drivers no more

webFOG: A web tool to map genomic features onto genes.